These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 45984)

  • 1. [Method of determining contact prekallikrein and inhibitors of kallikrein in the blood plasma of man].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Meged' NF
    Lab Delo; 1975; (1):9-12. PubMed ID: 45984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Method of simultaneous determination of kallikrein, plasmin and thrombin precursors and inhibitors in human blood plasma].
    Gomazkov OA; Komissarova NV
    Biull Eksp Biol Med; 1976 May; 81(5):632-4. PubMed ID: 132976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Method of determining human and animal plasma kallikrein inhibitors].
    Surovikina MS; Fomina EE
    Biull Eksp Biol Med; 1981 May; 91(5):623-6. PubMed ID: 6911028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kallikrein and prorenin in patients with hereditary angioedema.
    Purdon AD; Schapira M; De Agostini A; Colman RW
    J Lab Clin Med; 1985 Jun; 105(6):694-9. PubMed ID: 3889200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A simplified method for determining kallikreinogen and kallikrein in human blood (plasma) under normal conditions and in several pathologic states].
    Paskhina TS; Krinskaia AV
    Vopr Med Khim; 1974; 20(6):660-3. PubMed ID: 4450536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prekallikrein and kallikrein inhibitors in the blood plasma in viral hepatitis in children].
    Kramariev SO
    Pediatr Akus Ginekol; 1979; (6):9-11. PubMed ID: 534554
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
    Gallimore MJ
    Scand J Clin Lab Invest Suppl; 1985; 178():127-32. PubMed ID: 3867113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of prekallikrein in human plasma.
    Briseid K; Dyrud OK; Arntzen FC
    Acta Pharmacol Toxicol (Copenh); 1968; 26(5):395-401. PubMed ID: 5755306
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of kininogenesis indices].
    Surovikina MS; Maslikova GV; Fomina EE
    Biull Eksp Biol Med; 1983 May; 95(5):106-9. PubMed ID: 6552200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of kallikreinogen and kallikrein inhibitors in blood plasma].
    Veremiienko KM; Volokhons'kaia LI; Kizim OI; Meged' NF
    Ukr Biokhim Zh; 1974; 46(2):246-51. PubMed ID: 4545315
    [No Abstract]   [Full Text] [Related]  

  • 13. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Method for determining kallikrein of tissue origin in blood plasma and its clinical significance].
    Surovkina MS; Semenova LV; Semenov VI; Lapshina IM; Volkova TV
    Biull Eksp Biol Med; 1985 Aug; 100(8):249-52. PubMed ID: 3849314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein activates prothrombin.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):97-8. PubMed ID: 18160576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the kallikrein-kinin system in chronic hemodialysis patients].
    Jankova T; Nenov D
    Z Urol Nephrol; 1982 Feb; 75(2):81-4. PubMed ID: 6918181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a chromatographic method for determining kallikrein and prekallikrein in dog blood serum].
    Dotsenko VL; Saiapin VN; Neshkova EA; Iarovaia GA
    Biull Eksp Biol Med; 1982 Aug; 94(8):117-20. PubMed ID: 6922725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a microassay for human plasma prekallikrein.
    De La Cadena RA; Scott CF; Colman RW
    J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of plasma prekallikrein and kallikrein inhibitors during intravenous phlebography.
    Aronen HJ; Torstila I; Vahtera E; Suoranta HT
    Eur J Radiol; 1988 Feb; 8(1):30-3. PubMed ID: 2451609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.